CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results
Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma
What to do with BRAF-mutant melanoma patients who have a poor prognosis?
Global differences in cancer drug prices: a comparative analysis
Genetic testing in familial melanoma
Maria Concetta Fargnoli